Bicycle Therapeutics PLC (BCYC)
22.19
+0.27
(+1.23%)
USD |
NASDAQ |
May 31, 16:00
22.19
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Accounts Payable (Quarterly): 7.061M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 7.061M |
December 31, 2023 | 13.05M |
September 30, 2023 | 8.493M |
June 30, 2023 | 5.25M |
March 31, 2023 | 2.813M |
December 31, 2022 | 6.472M |
September 30, 2022 | 7.057M |
June 30, 2022 | 4.859M |
March 31, 2022 | 3.999M |
December 31, 2021 | 2.721M |
September 30, 2021 | 1.761M |
Date | Value |
---|---|
June 30, 2021 | 3.471M |
March 31, 2021 | 0.996M |
December 31, 2020 | 1.365M |
September 30, 2020 | 2.056M |
June 30, 2020 | 3.338M |
March 31, 2020 | 4.434M |
December 31, 2019 | 1.949M |
September 30, 2019 | 1.992M |
June 30, 2019 | 2.569M |
March 31, 2019 | 2.241M |
December 31, 2018 | 1.887M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.996M
Minimum
Mar 2021
13.05M
Maximum
Dec 2023
4.285M
Average
3.404M
Median
Accounts Payable (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 0.40M |
NuCana PLC | 7.277M |
Verona Pharma PLC | 4.651M |
TC BioPharm (Holdings) PLC | 2.434M |
Adaptimmune Therapeutics PLC | 6.587M |